An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine
Clinical trial NCT02873221 · COMPLETED
Trial details
- NCT number
- NCT02873221
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-13
- Primary completion
- 2018-08-02
- Enrollment
- 1254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.